Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD

Clinical trial NCT03824795 · COMPLETED

Trial details

NCT number: NCT03824795
Sponsor: MGB Biopharma Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2019-02-07
Primary completion: 2020-04-03
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.